Sabra Health Care

Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Sabra Health Care reports strong Q4 performance amidst Enlivant JV challenges

Sabra Health Care showcased improved performance in occupancy rates and revenue growth, with a strategic focus on senior housing opportunities.
Despite challenges from the Enlivant JV impact and market uncertainties, Sabra's strengths in debt management and asset operations position it well for future growth.
Opportunities lie in securing interest rates, expanding in the senior housing sector, and resolving uncertainties around the Enlivant JV for strategic advancement.
Addressing challenges such as transaction market dynamics and maintaining growth momentum will be crucial for Sabra's continued success in the healthcare real estate sector.

Sabra Health Care reports stable Q1 performance amidst market challenges

Sabra Health Care's Q1 2023 performance reflects stability and operational improvements in skilled nursing and senior housing portfolios.
While facing challenges in investment activity and rising debt financing rates, the company is leveraging opportunities in Medicaid rate increases and strategic investments.
Maintaining financial strength and flexibility, Sabra Health Care is poised to navigate market uncertainties and drive operational efficiency.

Sabra Health Care reports robust Q2 performance and eyes 2024 growth

Sabra Health Care's Q2 2023 earnings call highlighted positive performance metrics, ongoing margin recovery efforts, and strategic initiatives to drive occupancy and revenue growth. Despite challenges in the IL segment and market dynamics, the company's strong financial position and focus on portfolio optimization position it well for future opportunities.

Sabra Health Care posts robust Q3 results, eyes growth opportunities

Sabra Health Care's Q3 2023 earnings call reflects strong performance, portfolio stability, and growth potential. Challenges include maintaining coverage ratios and addressing analyst concerns. Opportunities exist in acquisitions, financing, and leveraging portfolio momentum.

Sabra Health Care reports strong Q4 performance and eyes industry growth opportunities

Sabra Health Care showcased strong performance in occupancy and financial metrics, with a focus on operational improvements and growth strategies.
While facing challenges related to occupancy levels and construction costs, the company remains optimistic about industry recovery and growth potential.
Opportunities in the skilled nursing space and sale-leaseback investments present avenues for expansion and strategic development.
Analysts' inquiries and discussions on acquisitions, regulatory issues, and financial guidance reflect a dynamic landscape with potential for strategic advancements.

Sabra Health Care reports solid Q3 performance amidst cautious outlook

Sabra Health Care's Q3 2024 earnings call reflected strong financial performance, strategic focus on quality investments, and cautious outlook on guidance and debt metrics. The company faces competition in skilled nursing but sees opportunities in acquisitions and margin improvement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

TUSTIN, Calif.--(BUSINESS WIRE)-- #REITworld--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Nareit's REITworld 2024 Annual Conference on November 19-20, 2024 at the Wynn Las Vegas in Las Vegas, Nevada. About Sabra Sabra Health C.

Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2024 Annual Conference

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q3 2024 Earnings Conference Call November 1, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Juan Sanabria - BMO Capital Michael Griffin - Citi Rich Anderson - Wedbush Alec Feygin - Baird Michael Stroyeck - Green Street Omotayo Okusanya - Deutsche Bank Operator Good day, everyone. My name is Adam, and I will be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q3 2024 Earnings Call Transcript

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to FFO of $0.34 per share a year ago.

Sabra Healthcare (SBRA) Q3 FFO and Revenues Surpass Estimates

TUSTIN, Calif.--(BUSINESS WIRE)-- #3Q24--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2024. THIRD QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2024 were as follows: Net Income: $0.13 FFO: $0.34 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.94x Senior Housing - Leased: 1.37x Behavi.

Sabra Reports Third Quarter 2024 Results; Updates 2024 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)-- #Moodys--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) announced today that Moody's Ratings (“Moody's”) issued a report on October 17, 2024 affirming Sabra's Ba1 ratings and upgrading Sabra's outlook to “Positive” from “Stable”. The report credits Sabra's upgraded outlook to improving industry fundamentals for skilled nursing and senior housing, which is driving an improvement in Sabra's key credit metrics, particularly net debt to EBITDA. For additional informat.

Moody's Upgrades Sabra Health Care REIT, Inc.'s Outlook to Positive, Affirms Credit Rating

TUSTIN, Calif.--(BUSINESS WIRE)-- #3Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.

Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call

TUSTIN, Calif.--(BUSINESS WIRE)-- #asha--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, and Lauren Nisley, the company's Director of Investments, will attend the INVEST Conference on October 7-9, 2024 at the JW Marriott Dallas Arts District in Dallas, Texas. Talya Nevo-Hacohen, the company's.

Sabra Health Care REIT, Inc. to Attend Fall Conferences

Sabra Healthcare REIT is showing a strong turnaround with impressive Q2 earnings, driven by increased occupancy and NOI growth, particularly in senior housing. The REIT's deleveraging efforts and strong liquidity position it well for future investments, with no debt maturing before 2026 and investment-grade ratings. Dividend growth is expected to resume in 2025, with management raising AFFO guidance, suggesting potential for share price appreciation despite lagging peers.

Sabra Health Care REIT: Turning The Corner

Digital Realty Trust

Iron Mountain

Medical Properties Trust

National Retail Properties

Realty Income Corp

Omega Healthcare Investors

Simon Property Group

Vici Properties

W. P. Carey

Equity REITs, distinct from mortgage REITs, generate income from rental leases and capital appreciation, offering high yields and tax advantages by distributing 90% of taxable income. My portfolio, Rose's Income Garden (RIG), includes six of the ten highlighted REITs, chosen for their credit ratings, yields, and growth potential. Interest rates significantly impact REIT prices; current high valuations may not last, but lower rates could enhance future pricing and investment opportunities.

10 Sweet REITs: Yield Up To 6.6%

TUSTIN, Calif.--(BUSINESS WIRE)-- #BAML--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate in the BofA Securities 2024 Global Real Estate Conference on September.

Sabra Health Care REIT, Inc. to Participate in the BofA Securities 2024 Global Real Estate Conference

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2024 Earnings Conference Call August 8, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank Austin Wurschmidt - KeyBanc Capital Markets Joshua Dennerlein - Bank of America Michael Griffin - Citigroup Vikram Malhotra - Mizuho Securities John Pawlowski - Wells Fargo Rich Anderson - Wedbush Securities Michael Stroyeck - Green Street Advisors, LLC Alec Feygin - Baird Equity Research Operator Good day, everyone. My name is Christina, and I will be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q2 2024 Earnings Call Transcript

While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sabra (SBRA) Reports Q2 Earnings: What Key Metrics Have to Say

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.36 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to FFO of $0.34 per share a year ago.

Sabra Healthcare (SBRA) Q2 FFO and Revenues Top Estimates

TUSTIN, Calif.--(BUSINESS WIRE)-- #2Q24--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2024. SECOND QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2024 were as follows: Net Income: $0.10 FFO: $0.35 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.85x Senior Housing - Leased: 1.35x Beh.

Sabra Reports Second Quarter 2024 Results; Increases 2024 Guidance

Get a deeper insight into the potential performance of Sabra (SBRA) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Sabra (SBRA) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

TUSTIN, Calif.--(BUSINESS WIRE)-- #2023ESG--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today released its fourth annual Sustainability Report for the fiscal year 2023. The report showcases our programs, policies and initiatives that support our ESG priorities of environmental stewardship; diversity, equity and inclusion; human capital management; protection of health, wellness and safety of our teammates; engagement and collaboration with our operators and tenants; cybers.

Sabra Publishes Fourth Annual Sustainability Report

TUSTIN, Calif.--(BUSINESS WIRE)-- #2Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 second quarter earnings release on August 7, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 second quarter results will be held on Thursday, August 8 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.

Sabra Health Care REIT, Inc. Announces Second Quarter 2024 Earnings Release Date and Conference Call

High interest rates have pressured businesses, but lower rates are expected to provide relief soon, particularly for REITs. Sabra Health Care REIT is poised to benefit from lower interest rates and an aging population. Despite lower occupancy levels, SBRA is expected to outperform peers with solid growth of 4.75% over the next 3 years.

Sabra Health Care REIT: 2 Catalysts That Should Ignite Solid Growth

Merck

PNC Financial Services

AT&T

24/7 Insights With the S&P 500 up 15% year-to-date, a correction could be coming in the third quarter.

Deutsche Bank Has 4 Sizzling ‘Fresh Money' Dividend Stock Picks for Q3

Voya Global Equity Dividend and Premium Opportunity Fund

Mach Natural Resources LP

Virtus AllianzGI Equity & Convertible Income Fund

Oxford Lane Capital

Rithm Capital Corp

TORM

USA Compression Partners

24/7 Wall Street Insights With inflation showing few signs of appreciable reversal, prices for other goods and services will inevitably continue to rise.

Want $22,500 in Passive Income? Invest $20,000 in These Dividend Stocks

American Healthcare REIT Inc

Alexandria Real Estate Equities

Community Healthcare Trust

CareTrust REIT

Diversified Healthcare Trust

Healthpeak Properties Inc

Global Medical REIT

Healthcare Realty Trust Inc

LTC Properties

National Health Investors

Universal Health Realty Income Trust

Vanguard Real Estate ETF

Ventas

Welltower

Healthcare REITs performed well during the recent earnings season. The sector showed strength and resilience in the face of economic challenges, and enjoys strong tailwinds from the aging of the U.S. population. This article examines growth, balance sheet, dividend, and valuation metrics of 16 Healthcare REITs, to identify the best investment from this sector.

Picking A Winner In Healthcare REITs

TUSTIN, Calif.--(BUSINESS WIRE)-- #NAREIT--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Jessica Flores, the company's Chief Accounting Officer, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate in Nareit's REITweek 2024 Investor Conference June 4 – 6, 2024 at the New York Hilto.

Sabra Health Care REIT, Inc. to Participate in Nareit's REITweek 2024 Investor Conference

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q1 2024 Earnings Conference Call May 9, 2024 1:00 PM ET Company Participants Lukas Hartwich - SVP, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Austin Wurschmidt - KeyBanc Joshua Dennerlein - Bank of America Michael Griffin - Citigroup Vikram Malhotra - Mizuho Rich Anderson - Wedbush Michael Stroyeck - Green Street Operator Good day everyone. My name is Katherine and I will be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q1 2024 Earnings Call Transcript

Sabra Health Care REIT has outperformed the Vanguard Real Estate Index Fund ETF in 2024. I expect the robust performance to continue, with the company confirming its normalized FFO outlook of $1.36/share, up 4.6% Y/Y.

News for Sabra Health Care Stock (SBRA)